JavaScript seem to be disabled in your browser.
You must have JavaScript enabled in your browser to utilize the functionality of this website.
ELISA: when used at a concentration of 8-9 µg/ml (assuming 100 µl/well antibody solution), in conjunction with biotinylated antigen affinity purified anti-human IL11 as the detection antibody at a concentration of at least 2 µg/ml, allows the detection of at least 0.2 ng/well.
Neutralization: requires a concentration of 2.4-3.6 µg/ml to yield one-half maximal inhibition [ND50] of the biological activity of human IL11 (5.0 ng/ml).
Immunostaining: This antibody stained human brain stroke (including control cortex and stroke core areas) tissue. The primary antibody was incubated at 2.5 μg/ml overnight at 2-8˚C This was followed by a fluorophore conjugated secondary antibody.
The optimal concentration should be determined by the user for each specific application.